SCHEMBL8720601

SCHEMBL8720601

O=S(=O)(Cl)OCCOS(=O)(=O)Cl

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 9/20 0.33
CA2 P00918 9/20 0.33
CA9 Q16790 7/20 0.33
KDM4E B2RXH2 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MMP9 P14780 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
CA12 O43570 2/20 0.32
CA3 P07451 2/20 0.32
CA4 P22748 2/20 0.32
CA6 P23280 2/20 0.32
CA5A P35218 2/20 0.32
CA7 P43166 2/20 0.32
CA14 Q9ULX7 2/20 0.32
CA5B Q9Y2D0 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27284056 0.85
SCHEMBL7575729 0.83
SCHEMBL3270913 0.81
SCHEMBL1524940 0.81
SCHEMBL11791936 0.81 ALDH1A1 (0.44) CA1CA2ALDH1A1TSHR
SCHEMBL11730088 0.78
SCHEMBL2263022 0.77
Chloroprene SCHEMBL9198743 0.77 TSHR (0.32) CA2CA9ALDH1A1TSHR
SCHEMBL701979 0.76
SCHEMBL219170 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102317063-A Multi-layer tube for an automatic transmission DYTECH DYNAMIC FLUID TECHNOLOG 2012-01-11 CN claimed
US-4259462-A Hardenable composition containing diisopropylbenzene dihydroperoxide DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1981-03-31 US claimed
CN-102317063-A Multi-layer tube for an automatic transmission DYTECH DYNAMIC FLUID TECHNOLOG 2012-01-11 CN disclosed
US-7662908-B2 Process for the preparation of activated polythylene glycols RBA PHARMA INC. (CA) 2010-02-16 US disclosed
CN-100420875-C A toothed belt DAYCO EUROPE SRL (IT) 2008-09-24 CN disclosed
US-20080139854-A1 Process for the preparation of activated polyethylene glycols RBA PHARMA INC. (CA) 2008-06-12 US disclosed
US-7351787-B2 Process for the preparation of activated polyethylene glycols BIOARTIFICIAL GEL TECHNOLOGIES, INC. (CA) 2008-04-01 US disclosed
CN-1867789-A Toothed belt DAYCO EUROPE SRL (IT) 2006-11-22 CN disclosed
EP-0643179-B1 REFRACTORY HEAT-INSULATING PANEL IG TECH RES INC (JP) 1998-12-16 EP disclosed
US-5678369-A Refractory/heat insulating panels IG-TECHNICAL RESEARCH INC. (JP) 1997-10-21 US disclosed
EP-0643179-A1 REFRACTORY HEAT-INSULATING PANEL IG-TECHNICAL RESEARCH INC. (JP) 1995-03-15 EP disclosed
EP-0131938-B1 PREPARATION OF ELASTOMERIC, CHLOROSULFONATED ETHYLENE POLYMERS UNION CARBIDE CORPORATION (US) 1988-11-09 EP disclosed
US-4560731-A Preparation of elastomeric, chlorosulfonated ethylene polymers UNION CARBIDE CORPORATION (US) 1985-12-24 US disclosed
EP-0131938-A1 Preparation of elastomeric, chlorosulfonated ethylene polymers UNION CARBIDE CORPORATION (US) 1985-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139854-A1 Process for the preparation of activated polyethylene glycols POLI, PMAIP1, PARG CA1 1057/4885CA2 1065/4885CA9 743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.